Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

27.3%

3 terminated/withdrawn out of 11 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

3(42.9%)

Phase 2

1(14.3%)

7Total

Phase 4(3)

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT01742143Recruiting

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Role: collaborator

NCT01603316Phase 2Active Not Recruiting

Food: A Three-Arm Study Examining Food Insecurity Interventions

Role: collaborator

NCT04537936Not ApplicableRecruiting

Psychotherapy Intervention for Latinos With Adv Cancer

Role: collaborator

NCT04015609Not ApplicableRecruiting

Psychotherapy Intervention for Latinos With Advanced Cancer

Role: collaborator

NCT02726360Completed

Physician Use of Non-English Language Skills in Cancer Care

Role: collaborator

NCT02640521Not ApplicableWithdrawn

Smoking Cessation Peds Asthma

Role: collaborator

NCT01241526Phase 4Completed

The COPD Patient Management European Trial (COMET)

Role: collaborator

NCT00910273Phase 4Terminated

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients

Role: collaborator

NCT01473680Terminated

Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients

Role: collaborator

NCT01103596Completed

Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)

Role: collaborator

NCT00768053Phase 4Completed

Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients

Role: collaborator

All 11 trials loaded